用FOLFIRINOX治疗胰腺酸性细胞癌复发的病理完整反应

Katsuhito Teramatsu1, Nao Fujimori2, Masatoshi Murakami1

  • 1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

概括

胰腺酸性细胞癌 (PACC) 是罕见的,缺乏标准化疗. 修改后的FOLFIRINOX (mFFX) 在PACC肝转移病例中实现了病理完整反应,提供了新的治疗希望.